Ali Mariam, van Eldik Maaike J A, Rietkerken Stijn, Schoones Jan W, Kruyt Nyika D, Rinkel Gabriel J E, Wermer Marieke J H, Peters Sanne, Ruigrok Ynte M
Department of Neurology, Leiden University Medical Center, the Netherlands.
Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, the Netherlands.
Neurology. 2025 Apr 22;104(8):e213511. doi: 10.1212/WNL.0000000000213511. Epub 2025 Mar 28.
A 2005 review identified smoking, hypertension, and excessive alcohol intake as the most important risk factors of aneurysmal subarachnoid hemorrhage (aSAH), but data on other factors remained inconclusive. While aSAH is more prevalent in female participants, evidence on sex differences and female-specific factors remains limited. Comprehensive identification of all risk factors, including potential sex differences and female-specific factors, is essential for improving prevention and accurately assessing aSAH risk. We aimed to determine whether there is now greater certainty around previously inconclusive risk factors, identify any new emerging factors, and explore sex differences in both established and emerging risk factors.
We conducted a systematic review and meta-analysis of cohort and case-control studies on prevalent lifestyle exposures, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. These exposures included smoking, hypertension, alcohol abuse, oral contraception, hormone replacement therapy, hypercholesterolemia, rigorous physical activity, lean body mass index, and diabetes. We calculated pooled sex-specific relative risks (RRs) and odds ratios (ORs) with 95% CIs for overall risk and female-to-male ratios of RRs (RRRs) and ORs (RORs) for sex comparisons.
We included 67 studies (34 cohort [8 with sex-specific data], 33 case-control [6 with sex-specific data]; n = 5,743,262; 57% female). A sex-specific association was found for current smoking (RRR 1.53, 95% CI 1.05-2.23), but not for hypertension (RRR 1.50, 95% CI 0.78-2.89) or excessive alcohol intake (RRR 0.46, 95% CI 0.13-1.63). Regular rigorous exercise (RR 0.74, 95% CI 0.53-1.04; OR 0.69, 95% CI 0.57-0.83) and diabetes (RR 0.75, 95% CI 0.55-1.02; OR 0.52, 95% CI 0.41-0.65) were associated with reduced risk, without sex-specific associations. Data on hypercholesterolemia (RR 1.24, 95% CI 0.97-1.58; OR 0.52, 95% CI 0.37-0.74) and lean BMI (RR 1.31, 95% CI 1.15-1.50; OR 1.39, 95% CI 0.74-2.60) were inconsistent and showed no sex-specific associations. Hormone replacement therapy (RR 1.03, 95% CI 0.72-1.48) and oral contraceptive use (RR 5.40, 95% CI 0.68-42.57) were limited to female patients, with current users compared with never users. Most studies contained potential sources of bias.
Current smoking, but not hypertension or excessive alcohol, has a stronger association with aSAH in female patients than in male patients. Regular exercise and diabetes are associated with a reduced risk, with no sex-specific associations. Data on female-specific factors remain inconsistent. Targeted smoking prevention may particularly benefit female patients. Large-scale studies are needed to clarify the role of female-specific factors in explaining the higher incidence of aSAH in female patients.
2005年的一项综述确定吸烟、高血压和过量饮酒是动脉瘤性蛛网膜下腔出血(aSAH)最重要的危险因素,但关于其他因素的数据仍无定论。虽然aSAH在女性参与者中更为普遍,但关于性别差异和女性特定因素的证据仍然有限。全面识别所有危险因素,包括潜在的性别差异和女性特定因素,对于改善预防措施和准确评估aSAH风险至关重要。我们旨在确定先前不确定的危险因素现在是否有更大的确定性,识别任何新出现的因素,并探讨既定和新出现危险因素中的性别差异。
我们按照系统评价和Meta分析的首选报告项目声明,对关于常见生活方式暴露的队列研究和病例对照研究进行了系统评价和Meta分析。这些暴露包括吸烟、高血压、酗酒、口服避孕药、激素替代疗法、高胆固醇血症、剧烈体育活动、瘦体重指数和糖尿病。我们计算了合并的性别特异性相对风险(RRs)和比值比(ORs)以及95%置信区间(CIs)用于总体风险,并计算了RRs(RRRs)和ORs(RORs)的女性与男性比值用于性别比较。
我们纳入了67项研究(34项队列研究[8项有性别特异性数据],33项病例对照研究[6项有性别特异性数据];n = 5,743,262;57%为女性)。发现当前吸烟存在性别特异性关联(RRR 1.53,95% CI 1.05 - 2.23),但高血压(RRR 1.50,95% CI 0.78 - 2.89)或过量饮酒(RRR 0.46,95% CI 0.13 - 1.63)不存在性别特异性关联。规律的剧烈运动(RR 0.74,95% CI 0.53 - 1.04;OR 0.69,95% CI 0.57 - 0.83)和糖尿病(RR 0.75,95% CI 0.55 - 1.02;OR 0.52,95% CI 0.41 - 0.65)与风险降低相关,且无性别特异性关联。关于高胆固醇血症(RR 1.24,95% CI 0.97 - 1.58;OR 0.52,95% CI 0.37 - 0.74)和低体重指数(RR 1.31,95% CI 1.15 - 1.50;OR 1.39,95% CI 0.74 - 2.60)的数据不一致,且无性别特异性关联。激素替代疗法(RR 1.03, 95% CI 0.72 - 1.48)和口服避孕药使用(RR 5.40, 95% CI 0.68 - 42.57)仅限于女性患者,比较的是当前使用者与从未使用者。大多数研究存在潜在的偏倚来源。
当前吸烟与女性患者aSAH的关联比男性患者更强,而高血压或过量饮酒并非如此。规律运动和糖尿病与风险降低相关,且无性别特异性关联。关于女性特定因素的数据仍然不一致。有针对性的吸烟预防可能对女性患者特别有益。需要大规模研究来阐明女性特定因素在解释女性患者aSAH发病率较高方面的作用。